bioskin was delighted to celebrate 25 years of passion for dermatological trials in 2017.
Founded in 1992 by Dr Johannes Gassmueller and headquartered in Hamburg, Germany, bioskin is a full-service dermatology-specific CRO. From a tiny but motivated team of 3 people in 1992, bioskin has grown to almost 60 experts in their fields, thus becoming one of the leading dermatology CROs .
„We are proud to have helped so many sponsors bring dermatological drugs and medical devices to the market,“ said bioskin CEO Walter Wigger-Alberti, MD.
Since 1992, bioskin has been successfully managing Proof-of-Concept and Phase I-IV clinical trials. With a strong in-house knowledge for dermatology, bioskin partners with its sponsors to provide the best solutions for their clinical trials. The relationship with many sponsors extends to over a decade and with some to even over two decades.
As part of its 25th company anniversary, bioskin organized a half-day workshop on clinical trials in dermatology. Keynote speakers presented and critically assessed recent developments, study designs and endpoints in dermatological trials. Prof. Thomas Werfel discussed recent results of trials on the treatment of atopic dermatitis. Prof. Berthold Rzany reviewed the spectrum of botulinum toxines and dermal fillers. Acne and its treatment options were presented by Prof. Christos C. Zouboulis. A substantial overview about clinical trials in alopecia was given by Prof. Ulrike Blume-Peytavi and the workshop was rounded off with a presentation about psoriasis trials by Prof. Diamant Thaci.
In the evening all guests continued the celebration on the top of a skyscraper with a stunning view of the City of Hamburg and its port.